DBVT - Why DBV Technologies Stock Is Rising Today
Shares of DBV Technologies (NASDAQ: DBVT) were trading higher on Friday following the company's release of its full-year 2020 earnings report. Much more important than its financial results, however, the company provided encouraging regulatory updates. As of 3:27 p.m. EST today, the stock was up by 13.2%.
DBV Technologies is developing Viaskin Peanut, a potential peanut allergy treatment. Viaskin Peanut is a "peanut patch" that can stimulate a patient's immune system by gradually exposing the patient to increased amounts of peanut protein. The company submitted Viaskin Peanut for review to the Food and Drug Administration in August 2019. But in August 2020, the agency declined to approve the treatment because of concerns surrounding the effect of patch adhesion on its efficacy.
Image source: Getty Images.
For further details see:
Why DBV Technologies Stock Is Rising Today